CALC

CalciMedica, Inc. CALC

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$54.0K

Quarter to Jun 30

Net income

$-7.65M

Quarter to Jun 30

Free cash flow

$-4.62M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$9.11M total
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CALC

Earnings Per Share

13fpro.ai/company/CALC

Loading ratio trend…

About CalciMedica, Inc. (CALC): stock profile, AI score and financials

CalciMedica, Inc. (CALC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CALC is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), CalciMedica, Inc. reports quarterly revenue of $54.0K, net income of $-7.7M, free cash flow of $-4.6M. Top institutional holders of CALC by reported 13-F value include Woodline Partners, HEIGHTS CAPITAL MANAGEMENT, Squadron Capital Management, based on the most recent SEC filings. CALC trades on the Nasdaq exchange and files with the SEC under CIK 1534133. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CALC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CalciMedica, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1534133 →